A Phase 1 interventional study of Silodosin and Tamsulosin in Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi, sponsored by Armed Forces Institute of Urology, Rawalpindi. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-30.
Sponsored by Armed Forces Institute of Urology, Rawalpindi · Phase 1, Interventional, and Treatment
to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi.
to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi in our local setup to find out the optimal drug which promptly and quickly cures the disease thus enabling the person to return to routine activity with less adverse effects.
51 studies on the registry are indexed under Calculi; 6 are open to participants now.
This study's enrollment of 142 is above the median of 74 across 43 interventional studies indexed under Calculi.
Browse Calculi studies →Armed Forces Institute of Urology, Rawalpindi is the lead sponsor of 5 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The patients used Silodosin for ureteric calculi
Drug: Silodosin
The patients used Tamsulosin for ureteric calculi
Drug: Tamsulosin
The patients used Silodosin for Medical expulsive therapy of ureteric calculi
The patients used Tamsulosin for Medical expulsive therapy of ureteric calculi
Stone clearance rate
Stone clearance rate
Time frame: upto 4 weeks
Stone expulsion time
Stone expulsion time
Time frame: upto 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2022 to primary completion in Feb 2023, 5 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drugs tested here: Silodosin · Tamsulosin
Armed Forces Institute of Urology, Rawalpindi